Lee Jeong-Won, Kim Chul Jung, Lee Ji Eun, Lee Sun-Joo, Kim Byoung Gie, Lee Je-Ho, Bae Duk-Soo, Park Chang-Soo
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Med Sci. 2005 Jun;20(3):468-72. doi: 10.3346/jkms.2005.20.3.468.
The aim of this study was to assess the efficacy and safety of laparoscopic treatment for adnexal cystic masses that were predicted to be benign in postmenopausal women. Postmenopausal women found to have an adnexal cystic mass were retrospectively evaluated with transvaginal ultrasonography, and serum CA-125 levels. The selection criteria were adnexal cystic masses greater than 3 cm but less than 10 cm, the masses were in the benign range (4-8) of Sassone's scoring system for transvaginal ultrasonography, and the patients had serum CA-125 levels less than 65 IU/mL. Two hundred nineteen women fulfilled the criteria and underwent operative laparoscopy. Almost all the masses (99.5%) were accurately predicted to be benign except for one borderline ovarian tumor. Two hundreds thirteen (97.3%) women were successfully managed by operative laparoscopy and six (2.7%) required laparotomy. For the patients managed by laparoscopy, the mean operative time was 51.3 min; the mean hospital stay was 2.5 days. There was no significant morbidity and surgery-related mortality. The combination of the Sassone's scoring system for transvaginal ultrasonography and serum CA-125 level can accurately predict benign cystic masses, and operative laparoscopy is technically feasible and safe for the management of adnexal mass in postmenopausal women.
本研究的目的是评估腹腔镜治疗绝经后妇女附件囊性肿物(预计为良性)的疗效和安全性。对发现有附件囊性肿物的绝经后妇女进行经阴道超声及血清CA-125水平的回顾性评估。选择标准为附件囊性肿物大于3 cm但小于10 cm,肿物在经阴道超声Sassone评分系统的良性范围内(4-8分),且患者血清CA-125水平小于65 IU/mL。199名妇女符合标准并接受了腹腔镜手术。除1例卵巢交界性肿瘤外,几乎所有肿物(99.5%)均被准确预测为良性。213名(97.3%)妇女通过腹腔镜手术成功治疗,6名(2.7%)需要开腹手术。对于接受腹腔镜手术的患者,平均手术时间为51.3分钟;平均住院时间为2.5天。无明显并发症及手术相关死亡。经阴道超声Sassone评分系统与血清CA-125水平相结合可准确预测良性囊性肿物,腹腔镜手术在技术上对绝经后妇女附件肿物的治疗是可行且安全的。